Meyenburg Jason Patrick 4
4 · Gemini Therapeutics, Inc. /DE · Filed May 18, 2021
Insider Transaction Report
Form 4
Meyenburg Jason Patrick
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2021-05-14$9.46/sh+13,000$122,929→ 13,000 total
4 · Gemini Therapeutics, Inc. /DE · Filed May 18, 2021
Common Stock